Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19497070rdf:typepubmed:Citationlld:pubmed
pubmed-article:19497070lifeskim:mentionsumls-concept:C0014644lld:lifeskim
pubmed-article:19497070lifeskim:mentionsumls-concept:C0024314lld:lifeskim
pubmed-article:19497070lifeskim:mentionsumls-concept:C0032520lld:lifeskim
pubmed-article:19497070lifeskim:mentionsumls-concept:C0599894lld:lifeskim
pubmed-article:19497070lifeskim:mentionsumls-concept:C0030695lld:lifeskim
pubmed-article:19497070lifeskim:mentionsumls-concept:C0392762lld:lifeskim
pubmed-article:19497070lifeskim:mentionsumls-concept:C1521840lld:lifeskim
pubmed-article:19497070lifeskim:mentionsumls-concept:C0332167lld:lifeskim
pubmed-article:19497070pubmed:issue5lld:pubmed
pubmed-article:19497070pubmed:dateCreated2009-10-6lld:pubmed
pubmed-article:19497070pubmed:abstractTextEpstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disease (PTLD) is a serious complication after allogeneic stem cell transplantation (SCT). The likelihood of PTLD is increased in the presence of specific risk factors. Monitoring of EBV DNA load and early administration of rituximab in patients with high EBV loads is recommended for high-risk patients.lld:pubmed
pubmed-article:19497070pubmed:languageenglld:pubmed
pubmed-article:19497070pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19497070pubmed:citationSubsetIMlld:pubmed
pubmed-article:19497070pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19497070pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19497070pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19497070pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19497070pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19497070pubmed:statusMEDLINElld:pubmed
pubmed-article:19497070pubmed:monthOctlld:pubmed
pubmed-article:19497070pubmed:issn1399-3062lld:pubmed
pubmed-article:19497070pubmed:authorpubmed-author:RingdénOOlld:pubmed
pubmed-article:19497070pubmed:authorpubmed-author:WiniarskiJJlld:pubmed
pubmed-article:19497070pubmed:authorpubmed-author:YueAAlld:pubmed
pubmed-article:19497070pubmed:authorpubmed-author:OmarHHlld:pubmed
pubmed-article:19497070pubmed:authorpubmed-author:MattssonJJlld:pubmed
pubmed-article:19497070pubmed:authorpubmed-author:LjungmanPPlld:pubmed
pubmed-article:19497070pubmed:authorpubmed-author:RembergerMMlld:pubmed
pubmed-article:19497070pubmed:authorpubmed-author:SundinMMlld:pubmed
pubmed-article:19497070pubmed:authorpubmed-author:LeBlancKKlld:pubmed
pubmed-article:19497070pubmed:authorpubmed-author:SparrelidEElld:pubmed
pubmed-article:19497070pubmed:authorpubmed-author:HägglundHHlld:pubmed
pubmed-article:19497070pubmed:authorpubmed-author:Gustafsson-Je...lld:pubmed
pubmed-article:19497070pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19497070pubmed:volume11lld:pubmed
pubmed-article:19497070pubmed:ownerNLMlld:pubmed
pubmed-article:19497070pubmed:authorsCompleteYlld:pubmed
pubmed-article:19497070pubmed:pagination393-9lld:pubmed
pubmed-article:19497070pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:19497070pubmed:meshHeadingpubmed-meshheading:19497070...lld:pubmed
pubmed-article:19497070pubmed:meshHeadingpubmed-meshheading:19497070...lld:pubmed
pubmed-article:19497070pubmed:meshHeadingpubmed-meshheading:19497070...lld:pubmed
pubmed-article:19497070pubmed:meshHeadingpubmed-meshheading:19497070...lld:pubmed
pubmed-article:19497070pubmed:meshHeadingpubmed-meshheading:19497070...lld:pubmed
pubmed-article:19497070pubmed:meshHeadingpubmed-meshheading:19497070...lld:pubmed
pubmed-article:19497070pubmed:meshHeadingpubmed-meshheading:19497070...lld:pubmed
pubmed-article:19497070pubmed:meshHeadingpubmed-meshheading:19497070...lld:pubmed
pubmed-article:19497070pubmed:meshHeadingpubmed-meshheading:19497070...lld:pubmed
pubmed-article:19497070pubmed:meshHeadingpubmed-meshheading:19497070...lld:pubmed
pubmed-article:19497070pubmed:meshHeadingpubmed-meshheading:19497070...lld:pubmed
pubmed-article:19497070pubmed:meshHeadingpubmed-meshheading:19497070...lld:pubmed
pubmed-article:19497070pubmed:meshHeadingpubmed-meshheading:19497070...lld:pubmed
pubmed-article:19497070pubmed:meshHeadingpubmed-meshheading:19497070...lld:pubmed
pubmed-article:19497070pubmed:meshHeadingpubmed-meshheading:19497070...lld:pubmed
pubmed-article:19497070pubmed:meshHeadingpubmed-meshheading:19497070...lld:pubmed
pubmed-article:19497070pubmed:meshHeadingpubmed-meshheading:19497070...lld:pubmed
pubmed-article:19497070pubmed:meshHeadingpubmed-meshheading:19497070...lld:pubmed
pubmed-article:19497070pubmed:meshHeadingpubmed-meshheading:19497070...lld:pubmed
pubmed-article:19497070pubmed:meshHeadingpubmed-meshheading:19497070...lld:pubmed
pubmed-article:19497070pubmed:meshHeadingpubmed-meshheading:19497070...lld:pubmed
pubmed-article:19497070pubmed:meshHeadingpubmed-meshheading:19497070...lld:pubmed
pubmed-article:19497070pubmed:year2009lld:pubmed
pubmed-article:19497070pubmed:articleTitleTargeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.lld:pubmed
pubmed-article:19497070pubmed:affiliationDepartment of Medicine, Huddinge, Division of Haematology, Karolinska Institutet, Stockholm, Sweden. hamdy.omar@ki.selld:pubmed
pubmed-article:19497070pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19497070pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19497070lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19497070lld:pubmed